PhoenixBio Co., Ltd. Stock Price

TSE:6190 Community·JP¥1.8b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

6190 Share Price Performance

JP¥436.00

109.00 (33.33%)

JP¥436.00

109.00 (33.33%)

JP¥436.00

Mon, 4 May 26

Share Pricen/a

6190 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Flawless balance sheet and slightly overvalued.

2 Risks

0 Rewards

View Full Analysis

PhoenixBio Co., Ltd. Key Details

Last Reported Earnings

Dec 31, 2025

Next Reporting Earnings

n/a

: -50.37
: 78.41%
: -12.83%
: 22.4%

View Full Analysis

About 6190

Founded: 2002
Employees: 69
CEO: Takashi Shimada
WebsiteView website: phoenixbio.co.jp

PhoenixBio Co., Ltd. provides contract testing services for medical product development in Japan, the United States, and internationally. The company offers PXB-mouse, a chimeric mouse with a humanized liver used in drug development experiments; and PXB-cells, human hepatocytes for in vitro studies and experiments, as well as HBV study services. Its products are used in gene therapeutics, MASH/MAFLD, viral hepatitis, DMPK/toxicity, and custom transplantations applications. The company was founded in 2002 and is headquartered in Higashihiroshima, Japan.